These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide. Zhou Z; Martin E; Sharina I; Esposito I; Szabo C; Bucci M; Cirino G; Papapetropoulos A Pharmacol Res; 2016 Sep; 111():556-562. PubMed ID: 27378567 [TBL] [Abstract][Full Text] [Related]
4. BAY58-2667 Activates Different Soluble Guanylyl Cyclase Species by Distinct Mechanisms that Indicate Its Principal Target in Cells is the Heme-Free Soluble Guanylyl Cyclase-Heat Shock Protein 90 Complex. Dai Y; Stuehr DJ Mol Pharmacol; 2023 May; 103(5):286-296. PubMed ID: 36868790 [TBL] [Abstract][Full Text] [Related]
5. Factors influencing the soluble guanylate cyclase heme redox state in blood vessels. Tawa M; Okamura T Vascul Pharmacol; 2022 Aug; 145():107023. PubMed ID: 35718342 [TBL] [Abstract][Full Text] [Related]
6. Thiol-Based Redox Modulation of Soluble Guanylyl Cyclase, the Nitric Oxide Receptor. Beuve A Antioxid Redox Signal; 2017 Jan; 26(3):137-149. PubMed ID: 26906466 [TBL] [Abstract][Full Text] [Related]
17. Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Dasgupta A; Bowman L; D'Arsigny CL; Archer SL Clin Pharmacol Ther; 2015 Jan; 97(1):88-102. PubMed ID: 25670386 [TBL] [Abstract][Full Text] [Related]
18. Reduced vascular responses to soluble guanylyl cyclase but increased sensitivity to sildenafil in female rats with type 2 diabetes. Goulopoulou S; Hannan JL; Matsumoto T; Ogbi S; Ergul A; Webb RC Am J Physiol Heart Circ Physiol; 2015 Jul; 309(2):H297-304. PubMed ID: 25957216 [TBL] [Abstract][Full Text] [Related]
19. The Role of sGC Stimulators and Activators in Heart Failure With Reduced Ejection Fraction. Cordwin DJ; Berei TJ; Pogue KT J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):593-600. PubMed ID: 34487435 [TBL] [Abstract][Full Text] [Related]
20. The Potential of sGC Modulators for the Treatment of Age-Related Fibrosis: A Mini-Review. Sandner P; Berger P; Zenzmaier C Gerontology; 2017; 63(3):216-227. PubMed ID: 27784018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]